[Managements and prognostic analyses in patients with invasive fungal rhinosinusitis]

W Zhou1, Q Liu1, W D Zhao2

  • 1Department of Otorhinolaryngology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai 200031, China.

Abstract

Insights

Invasive fungal sinusitis can be effectively managed with endoscopic debridement and intravenous antifungal therapy. This approach improves survival outcomes for patients with this serious fungal infection.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Radiology

Background:

  • Invasive fungal sinusitis (IFS) presents diagnostic and therapeutic challenges.
  • Understanding clinical features and outcomes is crucial for effective management.

Purpose of the Study:

  • To evaluate survival outcomes of invasive fungal sinusitis.
  • To analyze the clinical features, diagnostic intervals, and treatment efficacy.

Main Methods:

  • Retrospective analysis of 18 patients with histologically proven IFS (2006-2015).
  • Data collected included symptom onset to diagnosis interval, clinical presentation, CT/MRI findings, treatment, and prognosis.
  • Patients were categorized into acute (3) and chronic (15) IFS.

Main Results:

  • Mean delay from symptom onset to diagnosis was 5 months.
  • Common symptoms: headache (10/18), visual disturbance (7/18).
  • Complications included orbital apex (6/18), cavernous sinus (5/18), and intracranial extension (3/18). Aspergillus (15) and Mucor (3) were identified. Two patients recurred, one died.

Conclusions:

  • Endoscopic debridement combined with intravenous antifungals demonstrates efficacy.
  • Prompt diagnosis and multidisciplinary management are key for improving patient survival in IFS.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
602
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
413
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
999